171 related articles for article (PubMed ID: 11169768)
1. Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus.
Reneman L; De Bruin K; Lavalaye J; Gunning WB; Booij J
Synapse; 2001 Mar; 39(3):193-200. PubMed ID: 11169768
[TBL] [Abstract][Full Text] [Related]
2. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.
Booij J; Andringa G; Rijks LJ; Vermeulen RJ; De Bruin K; Boer GJ; Janssen AG; Van Royen EA
Synapse; 1997 Nov; 27(3):183-90. PubMed ID: 9329154
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.
Nikolaus S; Wirrwar A; Antke C; Arkian S; Schramm N; Müller HW; Larisch R
Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):308-13. PubMed ID: 15791440
[TBL] [Abstract][Full Text] [Related]
4. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
Laruelle M; Baldwin RM; Malison RT; Zea-Ponce Y; Zoghbi SS; al-Tikriti MS; Sybirska EH; Zimmermann RC; Wisniewski G; Neumeyer JL
Synapse; 1993 Apr; 13(4):295-309. PubMed ID: 7683143
[TBL] [Abstract][Full Text] [Related]
5. Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines.
Okada T; Fujita M; Shimada S; Sato K; Schloss P; Watanabe Y; Itoh Y; Tohyama M; Nishimura T
Nucl Med Biol; 1998 Jan; 25(1):53-8. PubMed ID: 9466362
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
Weikop P; Kehr J; Scheel-Krüger J
J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
[TBL] [Abstract][Full Text] [Related]
7. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
[TBL] [Abstract][Full Text] [Related]
8. Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats.
Booij J; Knol RJ; Reneman L; de Bruin K; Janssen AG; van Royen EA
Eur J Nucl Med; 1998 Dec; 25(12):1666-9. PubMed ID: 9871099
[TBL] [Abstract][Full Text] [Related]
9. 5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats.
Borycz J; Zapata A; Quiroz C; Volkow ND; Ferré S
Neuropsychopharmacology; 2008 Feb; 33(3):619-26. PubMed ID: 17487226
[TBL] [Abstract][Full Text] [Related]
10. Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.
Booij J; Tissingh G; Winogrodzka A; Boer GJ; Stoof JC; Wolters EC; van Royen EA
Eur J Nucl Med; 1997 Jan; 24(1):68-71. PubMed ID: 9044880
[TBL] [Abstract][Full Text] [Related]
11. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
12. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
[TBL] [Abstract][Full Text] [Related]
14. Serotonin transporter inhibition and 5-HT
Stewart A; Davis GL; Gresch PJ; Katamish RM; Peart R; Rabil MJ; Gowrishankar R; Carroll FI; Hahn MK; Blakely RD
Neuropsychopharmacology; 2019 Apr; 44(5):994-1006. PubMed ID: 30578419
[TBL] [Abstract][Full Text] [Related]
15. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers.
Lavalaye J; Booij J; Reneman L; Habraken JB; van Royen EA
Eur J Nucl Med; 2000 Jul; 27(7):867-9. PubMed ID: 10952500
[TBL] [Abstract][Full Text] [Related]
16. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
Johnson RA; Eshleman AJ; Meyers T; Neve KA; Janowsky A
Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886
[TBL] [Abstract][Full Text] [Related]
17. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats.
Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
J Neurochem; 1997 Dec; 69(6):2616-9. PubMed ID: 9375697
[TBL] [Abstract][Full Text] [Related]
18. The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists.
Fletcher PJ; Sinyard J; Higgins GA
Psychopharmacology (Berl); 2006 Sep; 187(4):515-25. PubMed ID: 16832658
[TBL] [Abstract][Full Text] [Related]
19. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
20. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative.
Zhou FC; Lesch KP; Murphy DL
Brain Res; 2002 Jun; 942(1-2):109-19. PubMed ID: 12031859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
